The Asian biomaterials market has witnessed dynamic market conditions, and is mainly driven by increased investments, funds & grants by government bodies worldwide, precipitous growth anticipated for plastic surgery and wound healing applications, inflated usage of polymers, growing number of elderly people, technological advancements, and changing lifestyles of the population.
The report ‘The Asian Biomaterials market forecast 2012-2014’ analyzes the market by technology devices into four segments, such as metals, ceramics, polymers, and natural biomaterial.
Incessant rise in the number of collaborations, conferences, and research-related activities, technological advancements, and increasing applications of biomaterials are the major factors propelling the growth of the biomaterial market in this region. Immunological and inflammatory reactions, stringent regulatory systems, issue of fatigue fracture & wear, and reimbursement concerns are the major restraints curbing the biomaterial market.
The Asian biomaterials market has witnessed a plethora of growth opportunities. Developments of novel biomaterials for healing wounds, plastic surgery, tissue engineering, ophthalmology, and neurology fuel the growth of this market. The burning issues affecting the growth of biomaterial market are challenges to tissue engineering and effect on suppliers by Biomaterials Access Assurance Act.
The Asian market growth will be driven by increasing government investments in the biomaterial sector, reimbursements offered by Center for Medicare and Medicaid Services (CMS), and rising aging population who are the main consumers of biomaterials. The Asian biomaterial market is expected to receive a significant push due to phenomenal increase in new products such as botox, botulinum toxins, and hyaluronic-based injectables.
Some of the key players in the Asian biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc., and others. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with the market data, you can also customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
- Country-specific prevalence of plastic surgery and wound healing applications
- Country-specific patient pool of plastic surgery and wound healing applications disease (pattern analysis)
Procedure Volume Data
- Plastic surgery and wound healing procedures performed annually in each country tracked till sub-segment level
- The number of plastic surgery and wound healing procedures performed in each country
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of biomaterials by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on plastic surgery data
Brand/Product Perception Matrix
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, and preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Biomaterials-Asia, By Applications
4.1 Neurological disorders/Central nervous system-Asia
4.1.1 Neurological disorders/Central nervous system-Asia, By MacroIndicators
22.214.171.124 Neurological disorders/Central nervous system-Healthcare Expenditure-Asia
4.2 Cardiovascular applications-Asia
4.2.1 Cardiovascular applications-Asia, By MacroIndicators
126.96.36.199 Cardiovascular applications-Healthcare Expenditure-Asia
4.3 Plastic Surgery (biomaterials)-Asia
4.3.1 Plastic Surgery (biomaterials)-Asia, By MacroIndicators
188.8.131.52 Plastic Surgery (biomaterials)-Healthcare Expenditure-Asia
4.4.1 Orthopedic-Asia, By MacroIndicators
184.108.40.206 Orthopedic-Healthcare Expenditure-Asia
4.4.2 Orthopedic-Asia, By Types
220.127.116.11 Spine Biomaterial-Asia
4.5 Wound Healing-Asia
4.5.1 Wound Healing-Asia, By MacroIndicators
18.104.22.168 Wound Healing-Healthcare Expenditure-Asia
4.6.1 Dental-Asia, By MacroIndicators
22.214.171.124 Dental-Healthcare Expenditure-Asia
4.7 Tissue Regeneration-Asia
4.7.1 Tissue Regeneration-Asia, By MacroIndicators
126.96.36.199 Tissue Regeneration-Healthcare Expenditure-Asia
4.8.1 Opthalmology-Asia, By MacroIndicators
188.8.131.52 Opthalmology-Healthcare Expenditure-Asia
5 Biomaterials-Asia, By Types
5.1 Polymer Biomaterials-Asia
5.2 Metallic Biomaterials-Asia
5.3 Ceramics Biomaterials-Asia
5.4 Natural Biomaterials-Asia
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
North American BioProduction Market
The North American bio-production Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “North American Bio-Production Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report also provides an extensive competitive landscaping of companies operating in this market.
European BioProduction Market
The European BioProduction Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “European BioProduction Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the European BioProduction Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European BioProduction Market also provides an extensive competitive landscaping of companies operating in this market.